Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × DLL3 protein, human × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Specimen Handling 339 pembrolizumab 293 Magnetic Resonance Spectroscopy 272 Carboplatin 199 Biopsy 179 Cyclophosphamide 174 Cisplatin 157 Paclitaxel 131 Gemcitabine 128 Bevacizumab 128 Radiotherapy 115 Nivolumab 113 fludarabine 111 venetoclax 107 Dexamethasone 93 Docetaxel 89 Fluorouracil 82 Pemetrexed 81 Oxaliplatin 81 Drug Therapy 75 Capecitabine 75 Rituximab 73 durvalumab 70 Blood Specimen Collection 70 Standard of Care 69 Leucovorin 67 Radiation 65 atezolizumab 63 Injections 63 Radiosurgery 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893783 2026-04-13

DeLLight

Asan Medical Center

Phase 2 Recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡